You are here

Article Text

Article menu
Download PDFPDF
Letter
Screening for Chlamydia trachomatis and Mycoplasma genitalium; is first void urine or genital swab best?
  1. Usha Hartgill1,
  2. Kiran Kalidindi2,
  3. Sol-Britt Molin1,
  4. Signe Ragnhild Kaste1
  1. 1Olafia Clinic, Department of Venereology, Oslo University Hospital, Oslo, Norway
  2. 2Beckenham, UK
  1. Correspondence to Dr Usha Hartgill, Olafia Clinic, Department of Venereology, Oslo University Hospital, Postboks 4763, 0506 Oslo, Norway; ushhar{at}ous-hf.no

https://doi.org/10.1136/sextrans-2014-051666

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In women the vulvovaginal swab has been established as the sample of choice for Chlamydia trachomatis.1 ,2 However, there is no consensus on the optimal sample for the detection of Mycoplasma genitalium.3–6

    Since 2008, all attendees to Olafia Clinic (Department of Venereology, Oslo University Hospital) have routinely been screened for C. trachomatis and M. genitalium. Following the publication of international guidelines recommending the vulvovaginal swab for C. trachomatis screening,1 we discontinued dual collection of first void urine (FVU) and genital swab in women …

    View Full Text

    Footnotes

    • Contributors SRK and S-BM collected the patient data. KK analysed the data. UH drafted the manuscript. All authors contributed to revision of the manuscript.

    • Competing interests None.

    • Ethics approval

    • Provenance and peer review Not commissioned; internally peer reviewed.